2024 Q3 Form 10-Q Financial Statement

#000146608524000092 Filed on August 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $160.1M $158.4M
YoY Change -5.02% -3.39%
Cost Of Revenue $1.249M $465.0K
YoY Change -98.23% -99.33%
Gross Profit $158.9M $157.9M
YoY Change 61.96% 66.13%
Gross Profit Margin 99.22% 99.71%
Selling, General & Admin $4.765M $6.244M
YoY Change 28.78% 5.65%
% of Gross Profit 3.0% 3.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $54.45M $53.76M
YoY Change -1.14% -0.42%
% of Gross Profit 34.27% 34.04%
Operating Expenses $60.03M $60.37M
YoY Change 1.22% 0.8%
Operating Profit $98.86M $97.57M
YoY Change 154.79% 177.4%
Interest Expense -$19.01M -$18.31M
YoY Change -186.28% -17.62%
% of Operating Profit -19.23% -18.77%
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income $12.62M $10.56M
YoY Change 215.5% -3.94%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $12.37M $10.35M
YoY Change 214.63% -3.31%
Net Earnings / Revenue 7.72% 6.54%
Basic Earnings Per Share $0.05 $0.05
Diluted Earnings Per Share $0.05 $0.05
COMMON SHARES
Basic Shares Outstanding 225.1M shares 225.1M shares
Diluted Shares Outstanding 226.1M shares 225.4M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.61M $21.03M
YoY Change 2.39% 46.59%
Cash & Equivalents $17.61M $21.03M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $0.00 $69.83M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $17.61M $90.86M
YoY Change -80.98% -9.97%
LONG-TERM ASSETS
Property, Plant & Equipment $5.741B $5.668B
YoY Change -8.48% -8.81%
Goodwill
YoY Change
Intangibles $1.158M $0.00
YoY Change 336.98%
Long-Term Investments $95.39M $90.35M
YoY Change 8.91% -9.62%
Other Assets $30.63M $26.36M
YoY Change -3.67% -6.39%
Total Long-Term Assets $5.931B $5.849B
YoY Change -8.55% -8.84%
TOTAL ASSETS
Total Short-Term Assets $17.61M $90.86M
Total Long-Term Assets $5.931B $5.849B
Total Assets $5.948B $5.940B
YoY Change -9.57% -8.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $119.3M $102.0M
YoY Change -13.87% -11.78%
Accrued Expenses $6.858M $9.150M
YoY Change -38.77% -17.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $14.69M $17.48M
YoY Change 406.69% 140.69%
Total Short-Term Liabilities $163.1M $165.6M
YoY Change -13.96% -3.08%
LONG-TERM LIABILITIES
Long-Term Debt $2.287B $2.235B
YoY Change -15.71% -15.45%
Other Long-Term Liabilities $9.745M $6.066M
YoY Change 24.94% -25.21%
Total Long-Term Liabilities $2.296B $2.241B
YoY Change -15.59% -15.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $163.1M $165.6M
Total Long-Term Liabilities $2.296B $2.241B
Total Liabilities $2.459B $2.407B
YoY Change -15.48% -18.73%
SHAREHOLDERS EQUITY
Retained Earnings -$416.2M -$392.6M
YoY Change 53.03% 63.61%
Common Stock $3.758B $3.757B
YoY Change 0.11% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.355B $3.399B
YoY Change
Total Liabilities & Shareholders Equity $5.948B $5.940B
YoY Change -9.57% -8.86%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $12.37M $10.35M
YoY Change 214.63% -3.31%
Depreciation, Depletion And Amortization $54.45M $53.76M
YoY Change -1.14% -0.42%
Cash From Operating Activities $69.24M $83.02M
YoY Change -8.66% 3.41%
INVESTING ACTIVITIES
Capital Expenditures $51.37M $43.93M
YoY Change -17.94% -21.77%
Acquisitions
YoY Change
Other Investing Activities -$16.24M $27.08M
YoY Change -516.44% -426.57%
Cash From Investing Activities -$67.61M -$16.85M
YoY Change 15.38% -73.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -784.0K -60.68M
YoY Change -92.67% 643.02%
NET CHANGE
Cash From Operating Activities 69.24M 83.02M
Cash From Investing Activities -67.61M -16.85M
Cash From Financing Activities -784.0K -60.68M
Net Change In Cash 845.0K 5.498M
YoY Change -87.0% -28.4%
FREE CASH FLOW
Cash From Operating Activities $69.24M $83.02M
Capital Expenditures $51.37M $43.93M
Free Cash Flow $17.87M $39.10M
YoY Change 35.38% 61.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
9723000 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
225122235 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
225122235 shares
CY2024Q2 irt Restricted Common Stock Shares Outstanding
RestrictedCommonStockSharesOutstanding
402249 shares
CY2023Q4 irt Restricted Common Stock Shares Outstanding
RestrictedCommonStockSharesOutstanding
288250 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2247000 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3754756000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3751942000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
34380000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
25513000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-392627000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-348405000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
3398760000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3431297000 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
134780000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
135897000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3533540000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3567194000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5940261000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6280175000 usd
CY2024Q2 irt Rental And Other Property Revenue
RentalAndOtherPropertyRevenue
158104000 usd
CY2023Q2 irt Rental And Other Property Revenue
RentalAndOtherPropertyRevenue
163601000 usd
CY2024Q2 us-gaap Other Income
OtherIncome
298000 usd
CY2023Q2 us-gaap Other Income
OtherIncome
354000 usd
CY2024Q2 us-gaap Revenues
Revenues
158402000 usd
CY2023Q2 us-gaap Revenues
Revenues
163955000 usd
CY2024Q2 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
60883000 usd
CY2023Q2 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
62071000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-72000 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-850000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1205000 usd
CY2024Q2 us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2023Q2 us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
10555000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
10988000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
201000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
279000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
10354000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
10555000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
10988000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
5065000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
18834000 usd
CY2024Q2 us-gaap Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net
InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
-5189000 usd
CY2023Q2 us-gaap Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net
InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
-4749000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-124000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14085000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10431000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
25073000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
198000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
642000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10233000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24431000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3567194000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
17961000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
36187000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9224000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3460000 usd
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1598000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2701000 usd
CY2024Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
189000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
409000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
412000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Other Liabilities
OtherLiabilities
8421000 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
2251000 usd
CY2024Q2 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
7666000 usd
CY2023Q2 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
6818000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6244000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5910000 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54127000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53984000 usd
CY2024Q2 irt Policyholder Benefits And Claims Incurred Net Property Casualty And Liability Gain Loss
PolicyholderBenefitsAndClaimsIncurredNetPropertyCasualtyAndLiabilityGainLoss
-465000 usd
CY2023Q2 irt Policyholder Benefits And Claims Incurred Net Property Casualty And Liability Gain Loss
PolicyholderBenefitsAndClaimsIncurredNetPropertyCasualtyAndLiabilityGainLoss
-680000 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
129385000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
129463000 usd
CY2023Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
10709000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224793229 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224422515 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225418825 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225073890 shares
us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
35557000 usd
irt Payments To Acquire Productive Assets Excluding Acquisition Of Real Estate Properties
PaymentsToAcquireProductiveAssetsExcludingAcquisitionOfRealEstateProperties
55698000 usd
irt Payments To Acquire Productive Assets Excluding Acquisition Of Real Estate Properties
PaymentsToAcquireProductiveAssetsExcludingAcquisitionOfRealEstateProperties
67199000 usd
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
30588000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
2406721000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2712981000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#DepreciationAndAmortization
us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#DepreciationAndAmortization
us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#DepreciationAndAmortization
CY2023Q2 us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#DepreciationAndAmortization
CY2024Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssets
CY2024Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilities
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
17460000 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
22227000 usd
CY2024Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-152000 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2024Q1 irt Distribution To Noncontrolling Interest Declared Per Share
DistributionToNoncontrollingInterestDeclaredPerShare
0.16
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
951000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3559103000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
10555000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2024Q2 us-gaap Dividends Common Stock
DividendsCommonStock
35966000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-124000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1940000 usd
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
945000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-72000 usd
CY2024Q2 irt Distribution To Noncontrolling Interest Declared Per Share
DistributionToNoncontrollingInterestDeclaredPerShare
0.16
CY2024Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
951000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3533540000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3737867000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
8872000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
31688000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10290000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4778000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3757000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-13000 usd
CY2023Q1 irt Distribution To Noncontrolling Interest Declared Per Share
DistributionToNoncontrollingInterestDeclaredPerShare
0.14
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
834000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3704935000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
10988000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
35906000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14085000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1785000 usd
CY2023Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
19000 usd
CY2023Q2 irt Distribution To Noncontrolling Interest Declared Per Share
DistributionToNoncontrollingInterestDeclaredPerShare
0.16
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
951000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3694917000 usd
us-gaap Profit Loss
ProfitLoss
28515000 usd
us-gaap Profit Loss
ProfitLoss
19861000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
107850000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
107520000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
4679000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
5493000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1379000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1763000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5250000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6462000 usd
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
10378000 usd
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
985000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
203000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
irt Amortization Or Adjustments Related To Derivative Instruments
AmortizationOrAdjustmentsRelatedToDerivativeInstruments
614000 usd
irt Amortization Or Adjustments Related To Derivative Instruments
AmortizationOrAdjustmentsRelatedToDerivativeInstruments
644000 usd
irt Policyholder Benefits And Claims Incurred Net Property Casualty And Liability Gain Loss And Other Adjustments
PolicyholderBenefitsAndClaimsIncurredNetPropertyCasualtyAndLiabilityGainLossAndOtherAdjustments
-1510000 usd
irt Policyholder Benefits And Claims Incurred Net Property Casualty And Liability Gain Loss And Other Adjustments
PolicyholderBenefitsAndClaimsIncurredNetPropertyCasualtyAndLiabilityGainLossAndOtherAdjustments
-831000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1679000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1981000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-891000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-5145000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4186000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7827000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9308000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1122000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
273000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-654000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1432000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
127080000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
127194000 usd
us-gaap Payments To Acquire Real Estate And Real Estate Joint Ventures
PaymentsToAcquireRealEstateAndRealEstateJointVentures
2982000 usd
us-gaap Payments To Acquire Real Estate And Real Estate Joint Ventures
PaymentsToAcquireRealEstateAndRealEstateJointVentures
21729000 usd
us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
320606000 usd
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
26884000 usd
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
3511000 usd
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
238553000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-83959000 usd
us-gaap Proceeds From Unsecured Lines Of Credit
ProceedsFromUnsecuredLinesOfCredit
131000000 usd
us-gaap Proceeds From Unsecured Lines Of Credit
ProceedsFromUnsecuredLinesOfCredit
125000000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
262652000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
97513000 usd
us-gaap Repayments Of First Mortgage Bond
RepaymentsOfFirstMortgageBond
159675000 usd
us-gaap Repayments Of First Mortgage Bond
RepaymentsOfFirstMortgageBond
3666000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
663000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
irt Payments Reimbursements For Deferred Financing Costs
PaymentsReimbursementsForDeferredFinancingCosts
357000 usd
irt Payments Reimbursements For Deferred Financing Costs
PaymentsReimbursementsForDeferredFinancingCosts
60000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
72104000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
63026000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1901000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1686000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2543000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3776000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
72000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
13000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-368967000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-44740000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3334000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1505000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50732000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44017000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47398000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42512000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21034000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14349000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
26364000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
28163000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47398000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42512000 usd
us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1: Organization</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Independence Realty Trust, Inc. (“IRT”), is a self-administered and self-managed Maryland real estate investment trust (“REIT”) which was formed on March 26, 2009. We are primarily engaged in the ownership, operation, management, improvement, and acquisition of multifamily apartment communities in non-gateway markets. As of June 30, 2024, we owned and operated 110 (unaudited) multifamily apartment properties (including one owned through a consolidated joint venture) that contain an aggregate of 32,685 (unaudited) units across non-gateway U.S. markets, including Atlanta, Columbus, Dallas, Denver, Houston, Indianapolis, Nashville, Oklahoma City, Raleigh-Durham, and Tampa. In addition, as of June 30, 2024, we owned two investments in real estate under development in Denver, Colorado that will, upon completion, contain an aggregate of 621 (unaudited) units. As of June 30, 2024, we also owned interests in four unconsolidated joint ventures, two of which own and operate multifamily apartment communities that contain an aggregate of 810 (unaudited) units and two of which are developing multifamily apartment properties that will, upon completion, contain an aggregate of 653 (unaudited) units. We own all of our assets and conduct substantially all of our operations through Independence Realty Operating Partnership, LP, a Delaware limited partnership (“IROP”), of which we are the sole general partner.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used herein, the terms “we,” “our,” and “us” refer to IRT and, as required by context, IROP and its subsidiaries.</span></div>
CY2024Q2 irt Number Of Real Estate Properties Excluding Development Properties
NumberOfRealEstatePropertiesExcludingDevelopmentProperties
110 property
CY2024Q2 irt Number Of Unconsolidated Joint Venture
NumberOfUnconsolidatedJointVenture
1 jointventure
CY2024Q2 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
32685 unit
irt Number Of Joint Ventures
NumberOfJointVentures
4 jointventure
CY2024Q2 irt Number Of Joint Ventures Own And Operate Apartment Communities
NumberOfJointVenturesOwnAndOperateApartmentCommunities
2 jointventure
CY2024Q2 irt Number Of Units In Developing Multifamily Apartment Community
NumberOfUnitsInDevelopingMultifamilyApartmentCommunity
810 unit
CY2024Q2 irt Number Of Operating Property
NumberOfOperatingProperty
2 property
CY2024Q2 irt Number Of Units In Operating Property Under Construction
NumberOfUnitsInOperatingPropertyUnderConstruction
653 unit
us-gaap Use Of Estimates
UseOfEstimates
Use of Estimates<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
26364000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
27880000 usd
CY2024Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P6M
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
66000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
399000 usd
CY2024Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
398000 usd
CY2023Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1099000 usd
CY2024Q2 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
15107000 usd
CY2023Q2 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2024Q2 us-gaap Depreciation
Depreciation
53757000 usd
us-gaap Depreciation
Depreciation
107080000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
53700000 usd
us-gaap Depreciation
Depreciation
106587000 usd
CY2024Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
8328000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
15604000 usd
CY2023Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
5114000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
8033000 usd
CY2024Q2 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
465000 usd
us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
2767000 usd
CY2023Q2 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
680000 usd
us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
831000 usd
CY2024Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1771000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
3341000 usd
CY2023Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1715000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
3168000 usd
CY2024Q2 us-gaap Real Estate Held For Development And Sale Net
RealEstateHeldForDevelopmentAndSaleNet
115196000 usd
CY2023Q4 us-gaap Real Estate Held For Development And Sale Net
RealEstateHeldForDevelopmentAndSaleNet
98365000 usd
CY2024Q2 irt Number Of Investments In Unconsolidated Real Estate Entities
NumberOfInvestmentsInUnconsolidatedRealEstateEntities
4 investment
CY2024Q2 irt Number Of Investments In Unconsolidated Real Estate Entities
NumberOfInvestmentsInUnconsolidatedRealEstateEntities
4 investment
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21034000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
21034000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22852000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
22852000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
26364000 usd
CY2024Q2 irt Restricted Cash And Cash Equivalents Fair Value Disclosure
RestrictedCashAndCashEquivalentsFairValueDisclosure
26364000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
27880000 usd
CY2023Q4 irt Restricted Cash And Cash Equivalents Fair Value Disclosure
RestrictedCashAndCashEquivalentsFairValueDisclosure
27880000 usd
CY2024Q2 irt Derivative Assets Carrying Value
DerivativeAssetsCarryingValue
38422000 usd
CY2024Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
38422000 usd
CY2023Q4 irt Derivative Assets Carrying Value
DerivativeAssetsCarryingValue
29937000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
29937000 usd
CY2024Q2 irt Indebtedness Associated With Real Estate Held For Sale Net
IndebtednessAssociatedWithRealEstateHeldForSaleNet
49598000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
15107000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2085000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2408000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2355000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
202000 usd
CY2023Q1 us-gaap Restructuring Costs
RestructuringCosts
3213000 usd
us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2024Q2 us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2024Q2 irt Number Of Real Estate Properties Excluding Development Properties
NumberOfRealEstatePropertiesExcludingDevelopmentProperties
110 property
irt Number Of Properties Owned By Joint Ventures
NumberOfPropertiesOwnedByJointVentures
1 property
CY2024Q2 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
32685 unit
CY2024Q2 us-gaap Land
Land
538151000 usd
CY2023Q4 us-gaap Land
Land
540950000 usd
CY2024Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5210283000 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
5288956000 usd
CY2024Q2 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
469585000 usd
CY2023Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
429306000 usd
CY2024Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6218019000 usd
CY2023Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
6259212000 usd
CY2024Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
667681000 usd
CY2023Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
582760000 usd
CY2024Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5550338000 usd
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
5676452000 usd
CY2023Q4 irt Number Of Properties Targeting For Sale
NumberOfPropertiesTargetingForSale
10 property
CY2023Q4 irt Number Of Markets Targeting Sale Of Properties
NumberOfMarketsTargetingSaleOfProperties
7 market
CY2024Q2 us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
28500000 usd
irt Number Of Properties Targeting For Sale
NumberOfPropertiesTargetingForSale
10 property
us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
525300000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
517100000 usd
CY2024Q2 irt Number Of Units In Real Estate Property Disposed
NumberOfUnitsInRealEstatePropertyDisposed
1746 housingunit
irt Sale Price Of Real Estate Property
SalePriceOfRealEstateProperty
324625000 usd
irt Gains Losses On Sales Of Investment Real Estate During Period
GainsLossesOnSalesOfInvestmentRealEstateDuringPeriod
25485000 usd
CY2023Q4 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
32956000 usd
CY2023Q4 irt Defeasance And Debt Prepayment Gains
DefeasanceAndDebtPrepaymentGains
1105000 usd
CY2024Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
15107000 usd
CY2024Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
318110000 usd
CY2024Q2 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
203789000 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-850000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1679000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1205000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1981000 usd
irt Equity Method Investment Number Of Units After Development Is Complete
EquityMethodInvestmentNumberOfUnitsAfterDevelopmentIsComplete
1463 unit
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
90347000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
89044000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2224371000 usd
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
9065000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-37253000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
2252559000 usd
CY2024Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.048
CY2024Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.041
us-gaap Debt Instrument Term
DebtInstrumentTerm
P3Y8M12D
CY2024Q2 irt Indebtedness Associated With Real Estate Held For Sale Net
IndebtednessAssociatedWithRealEstateHeldForSaleNet
49598000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
17479000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
136920000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
441285000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
23381000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1034789000 usd
CY2024Q2 irt Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
570517000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2515698000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
10772000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-44483000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2549409000 usd
CY2023Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.048
CY2023Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.042
CY2023 us-gaap Debt Instrument Term
DebtInstrumentTerm
P4Y
CY2023Q4 irt Indebtedness Associated With Real Estate Held For Sale Net
IndebtednessAssociatedWithRealEstateHeldForSaleNet
122621000 usd
CY2022Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
250000000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2024Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2024Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
250000000 usd
CY2023Q3 irt At Market Sales Agreement Maximum Offer Price Of Common Shares
AtMarketSalesAgreementMaximumOfferPriceOfCommonShares
450000000 usd
us-gaap Partners Capital Account Units Converted
PartnersCapitalAccountUnitsConverted
4928 shares
CY2024Q2 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
5941643 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1280610 shares
CY2024Q2 us-gaap Profit Loss
ProfitLoss
10555000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
10988000 usd
us-gaap Profit Loss
ProfitLoss
28515000 usd
us-gaap Profit Loss
ProfitLoss
19861000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
201000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
279000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
585000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
503000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
10354000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
10709000 usd
us-gaap Net Income Loss
NetIncomeLoss
27930000 usd
us-gaap Net Income Loss
NetIncomeLoss
19358000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224793229 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224422515 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224710259 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
224325246 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225418825 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225073890 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225403082 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225088261 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6070126 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6096634 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5946571 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5946571 shares
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001466085-24-000092-index-headers.html Edgar Link pending
0001466085-24-000092-index.html Edgar Link pending
0001466085-24-000092.txt Edgar Link pending
0001466085-24-000092-xbrl.zip Edgar Link pending
ex-311x2024630.htm Edgar Link pending
ex-312x2024630.htm Edgar Link pending
ex-321x2024630.htm Edgar Link pending
ex-322x2024630.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
irt-20240630.htm Edgar Link pending
irt-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
irt-20240630_cal.xml Edgar Link unprocessable
irt-20240630_def.xml Edgar Link unprocessable
irt-20240630_pre.xml Edgar Link unprocessable
irt-20240630_lab.xml Edgar Link unprocessable
irt-20240630_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending